Skip to main content Accessibility help
×
Home

Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity

  • Katherine Gil-Cardoso (a1), Iris Ginés (a1), Montserrat Pinent (a1), Anna Ardévol (a1), Mayte Blay (a1) and Ximena Terra (a1)...

Abstract

Diet-induced obesity is associated with low-grade inflammation, which, in most cases, leads to the development of metabolic disorders, primarily insulin resistance and type 2 diabetes. Although prior studies have implicated the adipose tissue as being primarily responsible for obesity-associated inflammation, the latest discoveries have correlated impairments in intestinal immune homeostasis and the mucosal barrier with increased activation of the inflammatory pathways and the development of insulin resistance. Therefore, it is essential to define the mechanisms underlying the obesity-associated gut alterations to develop therapies to prevent and treat obesity and its associated diseases. Flavonoids appear to be promising candidates among the natural preventive treatments that have been identified to date. They have been shown to protect against several diseases, including CVD and various cancers. Furthermore, they have clear anti-inflammatory properties, which have primarily been evaluated in non-intestinal models. At present, a growing body of evidence suggests that flavonoids could exert a protective role against obesity-associated pathologies by modulating inflammatory-related cellular events in the intestine and/or the composition of the microbiota populations. The present paper will review the literature to date that has described the protective effects of flavonoids on intestinal inflammation, barrier integrity and gut microbiota in studies conducted using in vivo and in vitro models.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: Dr Ximena Terra, fax +34 977 558232, email ximena.terra@urv.cat

Footnotes

Hide All

Contributed equally to the present review.

Footnotes

References

Hide All
1. Masoodi, M, Kuda, O, Rossmeisl, M, et al. (2015) Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta 1851, 503518.
2. Weisberg, SP, McCann, D, Desai, M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 17961808.
3. Cancello, R, Henegar, C, Viguerie, N, et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 22772286.
4. Hotamisligil, GS, Shargill, NS & Spiegelman, BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 8791.
5. Xu, H, Barnes, GT, Yang, Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 18211830.
6. Ding, S, Chi, MM, Scull, BP, et al. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5, e12191.
7. Teixeira, TFS, Collado, MC, Ferreira, CLLF, et al. (2012) Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32, 637647.
8. Bäckhed, F, Ding, H, Wang, T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 1571815723.
9. Bäckhed, F, Manchester, JK, Semenkovich, CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci 104, 979984.
10. Ley, RE, Bäckhed, F, Turnbaugh, P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 1107011075.
11. Power, SE, O’Toole, PW, Stanton, C, et al. (2014) Intestinal microbiota, diet and health. Br J Nutr 111, 387402.
12. Terra, X, Montagut, G, Bustos, M, et al. (2009) Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem 20, 210218.
13. Terra, X, Pallarés, V, Ardèvol, A, et al. (2011) Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J Nutr Biochem 22, 380387.
14. Azuma, T, Shigeshiro, M, Kodama, M, et al. (2013) Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 143, 827834.
15. Amasheh, M, Luettig, J, Amasheh, S, et al. (2012) Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro . Ann N Y Acad Sci 1258, 100107.
16. Etxeberria, U, Arias, N, Boqué, N, et al. (2015) Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem 26, 651660.
17. Massot-Cladera, M, Abril-Gil, M, Torres, S, et al. (2014) Impact of cocoa polyphenol extracts on the immune system and microbiota in two strains of young rats. Br J Nutr 112, 19441954.
18. Lee, HC, Jenner, AM, Low, CS, et al. (2006) Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 157, 876884.
19. Parkar, SG, Stevenson, DE & Skinner, MA (2008) The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 124, 295298.
20. Crozier, A, Jaganath, IB & Clifford, MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26, 10011043.
21. Manach, C, Scalbert, A, Morand, C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727747.
22. Thilakarathna, SH & Vasantha Rupasinghe, HP (2013) Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5, 33673387.
23. Del Rio, D, Rodriguez-Mateos, A, Spencer, JPE, et al. (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18, 18181892.
24. Quigley, EMM (2013) Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) 9, 560569.
25. Ley, R, Turnbaugh, P, Klein, S, et al. (2006) Human gut microbes associated with obesity. Nature 444, 10221023.
26. Hamilton, MK, Boudry, G, Lemay, DG, et al. (2015) Changes in intestinal barrier function and gut microbiota in high-fat diet fed rats are dynamic and region-dependent. Am J Physiol Gastrointest Liver Physiol 308, G840G851.
27. Damms-Machado, A, Mitra, S, Schollenberger, AE, et al. (2015) Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int 2015, 806248.
28. Remely, M, Tesar, I, Hippe, B, et al. (2015) Gut microbiota composition correlates with changes in body fat content due to weight loss. Benef Microbes 6, 431439.
29. Balzola, F, Bernstein, C, Ho, GT, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing: Commentary. Inflamm Bowel Dis Monit 11, 28.
30. Eckburg, PB, Bik, EM, Bernstein, CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 16351638.
31. Arumugam, M, Raes, J, Pelletier, E, et al. (2011) Enterotypes of the human gut microbiome. Nature 473, 174180.
32. Morgan, XC, Segata, N & Huttenhower, C (2013) Biodiversity and functional genomics in the human microbiome. Trends Genet 29, 5158.
33. O’Sullivan, Ó, Coakley, M, Lakshminarayanan, B, et al. (2013) Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother 68, 214221.
34. Aakko, J, Endo, A, Mangani, C, et al. (2015) Distinctive intestinal Lactobacillus communities in 6-month-old infants from rural Malawi and southwestern Finland. J Pediatr Gastroenterol Nutr 61, 641648.
35. Golubeva, AV, Crampton, S, Desbonnet, L, et al. (2015) Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology 60, 5874.
36. Penders, J, Thijs, C, Vink, C, et al. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511521.
37. Dethlefsen, L, Huse, S, Sogin, ML, et al. (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, e280.
38. Furet, J-P, Kong, L-C, Tap, J, et al. (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59, 30493057.
39. Turnbaugh, PJ, Hamady, M, Yatsunenko, T, et al. (2009) A core gut microbiom in obese and lean twins. Nature 457, 480484.
40. Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 10221023.
41. Duncan, SH, Lobley, GE, Holtrop, G, et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 32, 17201724.
42. Brandsma, E, Houben, T, Fu, J, et al. (2015) The immunity–diet–microbiota axis in the development of metabolic syndrome. Curr Opin Lipidol 26, 7381.
43. Aguirre, M, Jonkers, DMAE, Troost, FJ, et al. (2014) In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLOS ONE 9, e113864.
44. Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 17611772.
45. Zhou, X, Han, D, Xu, R, et al. (2014) A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet. PLOS ONE 9, e115148.
46. Manco, M, Putignani, L & Bottazzo, GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31, 817844.
47. Geurts, L, Neyrinck, AM, Delzenne, NM, et al. (2014) Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 5, 317.
48. Caricilli, AM & Saad, MJ (2013) The role of gut microbiota on insulin resistance. Nutrients 5, 829851.
49. Ravussin, Y, Koren, O, Spor, A, et al. (2012) Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) 20, 738747.
50. Blaut, M (2015) Gut microbiota and energy balance: role in obesity. Proc Nutr Soc 74, 227234.
51. de La Serre, CB, Ellis, CL, Lee, J, et al. (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440G448.
52. Serino, M, Luche, E, Gres, S, et al. (2011) Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61, 543553.
53. Raybould, HE (2012) Gut microbiota, epithelial function and derangements in obesity. J Physiol 590, 441446.
54. Laugerette, F, Furet, J-P, Debard, C, et al. (2012) Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. AJP Endocrinol Metab 302, E374E386.
55. Ghoshal, S, Witta, J, Zhong, J, et al. (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50, 9097.
56. Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 14701481.
57. Ghanim, H, Abuaysheh, S, Sia, CL, et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32, 22812287.
58. Kim, K-A, Gu, W, Lee, I-A, et al. (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLOS ONE 7, e47713.
59. Luo, H, Guo, P & Zhou, Q (2012) Role of TLR4/NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia. PLOS ONE 7, e46291.
60. Suzuki, T (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70, 631659.
61. Suzuki, M, Nagaishi, T, Yamazaki, M, et al. (2014) Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis. PLOS ONE 9, e88369.
62. Barreau, F & Hugot, JP (2014) Intestinal barrier dysfunction triggered by invasive bacteria. Curr Opin Microbiol 17, 9198.
63. Al-Sadi, R, Ye, D, Dokladny, K, et al. (2008) Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. J Immunol 180, 56535661.
64. Al-Sadi, R, Guo, S, Ye, D, et al. (2013) Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J Immunol 190, 65966606.
65. Ye, D & Ma, TY (2008) Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-α-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 12, 13311346.
66. Li, Q & Verma, IM (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2, 725734.
67. Hayden, MS, West, AP & Ghosh, S (2006) NF-κB and the immune response. Oncogene 25, 67586780.
68. Terra, X, Valls, J, Vitrac, X, et al. (2007) Grape-seed procyanidins act as antiinflammatory agents in endotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signaling pathway. J Agric Food Chem 55, 43574365.
69. Pahl, HL (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 68536866.
70. Toumi, R, Soufli, I, Rafa, H, et al. (2014) Probiotic bacteria Lactobacillus and Bifidobacterium attenuate inflammation in dextran sulfate sodium-induced experimental colitis in mice. Int J Immunopathol Pharmacol 27, 615627.
71. Wang, W, Xia, T & Yu, X (2015) Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro . Inflamm Res 64, 423431.
72. Kolios, G, Valatas, V & Ward, SG (2004) Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113, 427437.
73. Martinez-Micaelo, N, Gonzalez-Abuin, N, Terra, X, et al. (2012) Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation. Biochem J 441, 653663.
74. Du, CYQ, Choi, RCY, Dong, TTX, et al. (2014) Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures. PLOS ONE 9, e100382.
75. Atreya, I, Atreya, R & Neurath, MF (2008) NF-κB in inflammatory bowel disease. J Intern Med 263, 591596.
76. Yoshida, H, Watanabe, H, Ishida, A, et al. (2014) Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity. Biochem Biophys Res Commun 454, 95101.
77. Cao, Y, Bao, S, Yang, W, et al. (2014) Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet. Nutr Res 34, 10661074.
78. de la Garza, AL, Etxeberria, U, Palacios-Ortega, S, et al. (2014) Modulation of hyperglycemia and TNFα-mediated inflammation by helichrysum and grapefruit extracts in diabetic db/db mice. Food Funct 5, 21202128.
79. Jia, Z, Nallasamy, P, Liu, D, et al. (2015) Luteolin protects against vascular inflammation in mice and TNF-α-induced monocyte adhesion to endothelial cells via suppressing IKκBα/NF-κB signaling pathway. J Nutr Biochem 26, 293302.
80. Vazquez-Prieto, MA, Bettaieb, A, Haj, FG, et al. (2012) (–)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch Biochem Biophys 527, 113118.
81. Dou, W, Zhang, J, Sun, A, et al. (2013) Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling. Br J Nutr 110, 599608.
82. Esmaeili, MA & Alilou, M (2014) Naringenin attenuates CCl4-induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats. Clin Exp Pharmacol Physiol 41, 416422.
83. Aubry, C, Michon, C, Chain, F, et al. (2015) Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. Microb Cell Fact 14, 176.
84. Shon, W-J, Lee, Y-K, Shin, JH, et al. (2015) Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks. Sci Rep 5, 17305.
85. Nighot, P, Al-Sadi, R, Rawat, M, et al. (2015) Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Am J Physiol Gastrointest Liver Physiol 309, G988G997.
86. Ungaro, R, Fukata, M, Hsu, D, et al. (2009) A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296, G1167G1179.
87. Fiorotto, R, Scirpo, R, Trauner, M, et al. (2011) Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology 141, 14981508.e5.
88. Nepali, S, Son, J-S, Poudel, B, et al. (2015) Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway. Pharmacogn Mag 11, 627635.
89. Lin, P, Tian, X-H, Yi, Y-S, et al. (2015) Luteolin induced protection of H2O2 induced apoptosis in PC12 cells and the associated pathway. Mol Med Rep 12, 76997704.
90. Kim, JS & Jobin, C (2005) The flavonoid luteolin prevents lipopolysaccharide-induced NF-κB signalling and gene expression by blocking IκB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115, 375387.
91. Ruiz, PA & Haller, D (2006) Functional diversity of flavonoids in the inhibition of the proinflammatory NF-κB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr 136, 664671.
92. Nunes, C, Ferreira, E, Freitas, V, et al. (2013) Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells. Food Funct 4, 373383.
93. Matias, A, Nunes, SL, Poejo, J, et al. (2014) Antioxidant and anti-inflammatory activity of a flavonoid-rich concentrate recovered from Opuntia ficus-indica juice. Food Funct 5, 32693280.
94. Adams, LS, Seeram, NP, Aggarwal, BB, et al. (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54, 980985.
95. Biasi, F, Guina, T, Maina, M, et al. (2013) Phenolic compounds present in Sardinian wine extracts protect against the production of inflammatory cytokines induced by oxysterols in CaCo-2 human enterocyte-like cells. Biochem Pharmacol 86, 138145.
96. During, A & Larondelle, Y (2013) The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: structure–activity relationships of flavones. Biochem Pharmacol 86, 17391746.
97. Wen, X & Walle, T (2006) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos 34, 17861792.
98. Walle, T, Ta, N, Kawamori, T, et al. (2007) Cancer chemopreventive properties of orally bioavailable flavonoids – methylated versus unmethylated flavones. Biochem Pharmacol 73, 12881296.
99. Castagnini, C, Luceri, C, Toti, S, et al. (2009) Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols. Br J Nutr 102, 16201628.
100. Mascaraque, C, González, R, Suárez, MD, et al. (2015) Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium. Br J Nutr 113, 618626.
101. Larrosa, M, Luceri, C, Vivoli, E, et al. (2009) Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 53, 10441054.
102. Brun, P, Castagliuolo, I, Leo, V Di, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, 518525.
103. Chen, X, Zhao, H-X, Fu, X-S, et al. (2012) Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis. Pancreas 41, 10801085.
104. Suzuki, T & Hara, H (2009) Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr 139, 965974.
105. Hertog, MG, Hollman, PC & Katan, MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 40, 23792383.
106. Amasheh, M, Grotjohann, I, Amasheh, S, et al. (2009) Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor α and interferon γ in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44, 12261235.
107. Carrasco-Pozo, C, Morales, P & Gotteland, M (2013) Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression. J Agric Food Chem 61, 52915297.
108. Carrasco-Pozo, C, Gotteland, M & Speisky, H (2010) Protection by apple peel polyphenols against indometacin-induced oxidative stress, mitochondrial damage and cytotoxicity in Caco-2 cells. J Pharm Pharmacol 62, 943950.
109. Carrasco-Pozo, C, Speisky, H, Brunser, O, et al. (2011) Apple peel polyphenols protect against gastrointestinal mucosa alterations induced by indomethacin in rats. J Agric Food Chem 59, 64596466.
110. Sim, G-S, Lee, B-C, Cho, HS, et al. (2007) Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch Pharm Res 30, 290298.
111. Agullo, G, Gamet-Payrastre, L, Manenti, S, et al. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 16491657.
112. Eckert, JJ, McCallum, A, Mears, A, et al. (2004) Specific PKC isoforms regulate blastocoel formation during mouse preimplantation development. Dev Biol 274, 384401.
113. Helfrich, I, Schmitz, A, Zigrino, P, et al. (2007) Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol 127, 782791.
114. Suzuki, A, Yamanaka, T, Hirose, T, et al. (2001) Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 152, 11831196.
115. Banan, A, Farhadi, A, Fields, JZ, et al. (2003) The δ-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J Pharmacol Exp Ther 305, 482494.
116. Sheth, P, Basuroy, S, Li, C, et al. (2003) Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 278, 4923949245.
117. Peng, J-H, Cui, T, Huang, F, et al. (2013) Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. J Pharmacol Exp Ther 344, 646654.
118. Shiratori, Y, Teraoka, H, Matano, S, et al. (1989) Kupffer cell function in chronic ethanol-fed rats. Liver 9, 351359.
119. Bode, C & Christian Bode, J (2003) Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol 17, 575592.
120. Suzuki, T & Hara, H (2011) Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem 22, 401408.
121. Rao, RK, Basuroy, S, Rao, VU, et al. (2002) Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin–β-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 368, 471481.
122. Watson, JL, Ansari, S, Cameron, H, et al. (2004) Green tea polyphenol (–)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-γ but not by IL-4. Am J Physiol Gastrointest Liver Physiol 287, G954G961.
123. Jorth, P, Turner, KH, Gumus, P, et al. (2014) Metatranscriptomics of the human oral microbiome during health and disease. MBio 5, e01012e01014.
124. Guarner, F & Malagelada, J-R (2003) Gut flora in health and disease. Lancet 360, 512519.
125. Etxeberria, U, Fernández-Quintela, A, Milagro, FI, et al. (2013) Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem 61, 95179533.
126. Tzounis, X, Rodriguez-Mateos, A, Vulevic, J, et al. (2011) Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93, 6272.
127. Queipo-Ortuño, MI, Boto-Ordóñez, M, Murri, M, et al. (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95, 13231334.
128. Clavel, T, Fallani, M, Lepage, P, et al. (2005) Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr 135, 27862792.
129. Hage, FG & Szalai, AJ (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 50, 11151122.
130. Anhê, FF, Roy, D, Pilon, G, et al. (2015) A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64, 872883.
131. Axling, U, Olsson, C, Xu, J, et al. (2012) Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab (Lond) 9, 105.
132. Everard, A, Belzer, C, Geurts, L, et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110, 90669071.
133. Hildebrandt, MA, Hoffmann, C, Sherrill-Mix, SA, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 17161724.e1–2.
134. Rastmanesh, R (2011) High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact 189, 18.
135. Déprez, S, Brezillon, C, Rabot, S, et al. (2000) Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr 130, 27332738.
136. Cueva, C, Moreno-Arribas, MV, Martin-Alvarez, PJ, et al. (2010) Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. Res Microbiol 161, 372382.
137. Rechner, AR & Kroner, C (2005) Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res 116, 327334.
138. Karlsson, PC, Huss, U, Jenner, A, et al. (2005) Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J Nutr 135, 23432349.
139. Russell, WR, Drew, JE, Scobbie, L, et al. (2006) Inhibition of cytokine-induced prostanoid biogenesis by phytochemicals in human colonic fibroblasts. Biochim Biophys Acta 1762, 124130.
140. Gao, K, Xu, A, Krul, C, et al. (2006) Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J Nutr 136, 5257.
141. Glinghammar, B & Rafter, J (2001) Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology 120, 401410.
142. Lieber, CS & DeCarli, LM (1982) The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res 6, 523531.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed